Therapeutic efficacy of chloroquine and chloroquine plus primaquine for the treatment of Plasmodium vivax in Ethiopia
The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In Ethiopia, the treatment failure rate decreased from 5.6% with CQ to 0.75% with CQ–PQ [32], and studies in Thailand and Afghanistan also reported lower recurrence rates with CQ–PQ compared to CQ alone [36, 37].”
In the citing paper
“Although the therapeutic success on day 28 is lower than studies in Southwestern India (100%), Central China (100%), Brazil (100%), and Colombia (98.6%) [27–30], as well as two Ethiopian studies (Arbamich 100%, Bishoftu-Adama 99.2%) [31, 32], the day 42 success rate in this study is comparable to findings from Arbamich [31] but lower than those from India (100%) and China (96.1%) [33, 34].”
In the citing paper
“A clinical efficacy trial conducted at two sites in Ethiopia found that the risk of Plasmodium vivax relapse among patients treated with chloroquine plus primaquine was less than half of that observed in patients treated with chloroquine alone (26% and 62%, respectively) [9].”
In the citing paper
“The tremendous impact of primaquine on reducing the recurrence of P. vivax has been well documented, including in Ethiopia [9, 10, 31].”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Effects of Plasmodium vivax malaria in pregnancy.
Nosten, F., McGready, R., Simpson, J., Thwai, K., Balkan, S., Cho, T., Hkirijaroen, L., Looareesuwan, S., & White, N. (1999) · The Lancet · doi:10.1016/s0140-6736(98)09247-2 · Cited by 381
Morassin, B., Fabre, R., Berry, A., & Magnaval, J. F. (2002) · The American journal of tropical medicine and hygiene · doi:10.4269/ajtmh.2002.66.503 · Cited by 109
Research works printed but not linked: 27
- Baird, 2004, Chloroquine resistance in Plasmodium vivax. Minireview, Antimicrob. Agents Chemother., 48, 4075, 10.1128/AAC.48.11.4075-4083.2004 · DOI · Paper page
- Baird, 2007, Neglect of Plasmodium vivax malaria, Trends Parasitol., 23, 533, 10.1016/j.pt.2007.08.011 · DOI · Paper page
- Baird, 2004, Primaquine therapy for malaria, J. Infect. Dis., 39, 136
- Baird, 1991, Resistance to chloroquine by Plasmodium vivax in Irian Jaya, Indonesia, Am. J. Trop. Med. Hyg., 44, 547, 10.4269/ajtmh.1991.44.547 · DOI · Paper page
- Baird, 1997, Diagnosis of resistance to chloroquine by Plasmodium vivax: timing of recurrence and whole blood levels, Am. J. Trop. Med. Hyg., 56, 621, 10.4269/ajtmh.1997.56.621 · DOI · Paper page
- Baird, 1997, Whole blood chloroquine concentrations with Plasmodium vivax infection in Iranian Jaya, Indonesia, Am. J. Trop. Med. Hyg., 56, 618, 10.4269/ajtmh.1997.56.618 · doi:10.4269/ajtmh.1997.56.618
- Barcus, 2007, Demographic risk factors for severe and fatal vivax and falciparum malaria among hospital admissions in northeastern Indonesian Papua, Am. J. Trop. Med. Hyg., 77, 984, 10.4269/ajtmh.2007.77.984 · DOI · Paper page
- Bunnag, 1994, High dose of primaquine in primaquine resistant vivax malaria, Trans. R. Soc. Trop. Med. Hyg., 88, 218, 10.1016/0035-9203(94)90305-0 · doi:10.1016/0035-9203(94)90305-0
- Chen, 2007, Relapses of Plasmodium vivax infection result from clonal hypnozoites activated at predetermined intervals, J. Infect. Dis., 95, 934, 10.1086/512242 · DOI · Paper page
- Collins, 1996, Primaquine resistance in Plasmodium vivax, Am. J. Trop. Med. Hyg., 55, 243, 10.4269/ajtmh.1996.55.243 · DOI · Paper page
- Genton, B., D’Acremont, V., Rare, L., Baea, K., Reeder, J.C., Alpers, M.P., Müller I., 2008. Plasmodium vivax and mixed infections are associated with severe malaria in children: a prospective cohort study from Papua New Guinea. PLoS Med. 5, e127. doi:10.1371/journal.pmed.0050127. · DOI · Paper page
- Imwong, 2005, Practical PCR genotyping protocols for Plasmodium vivax using Pvcs and Pvmsp1, Malaria J., 4, 20, 10.1186/1475-2875-4-20 · DOI · Paper page
- Imwong, 2007, Relapses of Plasmodium vivax infection usually result from activation of heterologous hypnozoites, J. Infect. Dis., 195, 927, 10.1086/512241 · DOI · Paper page
- Jima, 2005, Therapeutic efficacy of sulfadoxine-pyrimethamine for the treatment of uncomplicated falciparum malaria in Ethiopia, East Afr. Med. J., 82, 391
- Looareesuwan, 1997, Primaquine-tolerant vivax malaria in Thailand, Ann. Trop. Med. Parasitol., 91, 939, 10.1080/00034989760338 · doi:10.1080/00034989760338
- Mendis, 2001, The neglected burden of Plasmodium vivax malaria, Am. J. Trop. Med. Hyg., 64, 97, 10.4269/ajtmh.2001.64.97 · DOI · Paper page
- Price, 2007, Vivax malaria: neglected and not benign, Am. J. Trop. Med. Hyg., 77, 79, 10.4269/ajtmh.2007.77.79 · DOI · Paper page
- Pukrittayakamee, 1994, Blood stage antimalarial efficacy of primaquine in Plasmodium vivax malaria, J. Infect. Dis., 169, 932, 10.1093/infdis/169.4.932 · DOI
- Rieckmann, 1989, Plasmodium vivax resistance to chloroquine?, The Lancet, 2, 1183, 10.1016/S0140-6736(89)91792-3 · DOI · Paper page
- Ruebush, 2003, Chloroquine-resistant Plasmodium vivax malaria in Peru, Am. J. Trop. Med. Hyg., 69, 548, 10.4269/ajtmh.2003.69.548 · doi:10.4269/ajtmh.2003.69.548
- Schwartz, 1999, Primaquine as prophylaxis for malaria for nonimmune travelers: a comparison with mefloquine and doxycycline, Clin. Infect. Dis., 29, 1502, 10.1086/313527 · DOI
- Schwartz, 2000, Short report: a consideration of primaquine dose adjustment for radical cure of Plasmodium vivax malaria, Am. J. Trop. Med. Hyg., 62, 393, 10.4269/ajtmh.2000.62.393 · doi:10.4269/ajtmh.2000.62.393
- Smoak, 1997, Plasmodium vivax infection in U.S. army troops: failure of primaquine to prevent relapse in studies from Somalia, Am. J. Trop. Med. Hyg., 56, 231, 10.4269/ajtmh.1997.56.231 · doi:10.4269/ajtmh.1997.56.231
- Tjitra, E., Anstey, N.M., Sugiarto, P., Warikar, N., Kenangalem, E., et al., 2008. Multidrug-resistant Plasmodium vivax associated with severe and fatal malaria. A prospective study in Papua, Indonesia. PLoS Med. 5, e128. doi:10.1371/journal.pmed.0050128. · DOI · Paper page
- Tulu, 1996, Failure of chloroquine treatment for malaria in the highlands of Ethiopia, Trans. R. Soc. Trop. Med. Hyg., 90, 556, 10.1016/S0035-9203(96)90322-3 · DOI · Paper page
- WHO, 2001. The use of anti-malarial drugs. Report of a WHO Informal Consultation. WHO/CDS/RBM/2001.33, pp. 34–35.
- Wilairatana, 1999, Efficacy of primaquine regimens for primaquine resistant Plasmodium vivax malaria in Thailand, Am. J. Trop. Med. Hyg., 61, 973, 10.4269/ajtmh.1999.61.973 · DOI
Cited by
Operational strategies to achieve and maintain malaria elimination
Moonen, B., Cohen, J. M., Snow, R. W., Slutsker, L., Drakeley, C., Smith, D. L., Abeyasinghe, R. R., Rodriguez, M. H., Maharaj, R., Tanner, M., et al. (2010) · The Lancet · doi:10.1016/s0140-6736(10)61269-x · Cited by 381
Getu, E., Biruksew, A., Eshetu, T., Abamecha, A., Assefa, D. G., Mohammed, H., Wuletaw, Y., Tasew, G., Tollera, G., Hailu, M., et al. (2025) · Malaria Journal · doi:10.1186/s12936-025-05446-y · Cited by 4
Shifraw, T., Abdelmenan, S., Zewde, A., Worku, A., Abera, A., Mohammed, H., Etana, K., Keating, J., Chibsa, S., Girma, S., et al. (2025) · Malaria Journal · doi:10.1186/s12936-025-05709-8
Metadata
- Authors
- Yeshiwondim, A. K., Tekle, A. H., Dengela, D. O., Yohannes, A. M., & Teklehaimanot, A.
- Venue
- Acta Tropica
- Publisher
- Elsevier BV
- Published
- 2010-02
- Volume
- 113
- Issue
- 2
- Pages
- 105-113
- ISSN
- 0001-706X
- Cited by
- 37
- References
- 2
- Language
- en
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Therapeutic efficacy of chloroquine and chloroquine plus primaquine for the treatment of Plasmodium vivax in Ethiopia. https://app.cochat.ai/papers/10.1016/j.actatropica.2009.10.001
- The paper
- Yeshiwondim, A. K., Tekle, A. H., Dengela, D. O., Yohannes, A. M., & Teklehaimanot, A. (2010). Therapeutic efficacy of chloroquine and chloroquine plus primaquine for the treatment of Plasmodium vivax in Ethiopia. Acta Tropica. https://doi.org/10.1016/j.actatropica.2009.10.001
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.